OxyDial Inc

Philadelphia, PA · Founded 2022 · Medtech · Private

Portable blood testing instrument and cloud platform measuring Oxygen-Hemoglobin Equilibrium

Claim this profile

Follows are private to you and power your alerts

Updated · oxydial.com

Sector
Medtech
Headquarters
Philadelphia, PA
Founded
2022
Latest Form D
$700K, May 2026
Total capital
$700K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$700K
1 Form D · last May 2026
5 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

2026FEDERAL ↑EQUITY ↓Cumulative $700K1st Form D$700K
2026FEDERAL ↑EQUITY ↓Cumulative $700K1st Form D$700K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$700K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Alexey AprelevExecutive Officer, DirectorNamed in SEC Form D filings
  • David AlbertDirectorNamed in SEC Form D filings
  • John YapaolaDirectorNamed in SEC Form D filings
  • Oleksandr ShestakovExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingSystem, Apparatus, and Method of Testing a Blood Sample or a Non-Blood Sample Capable of Transporting Oxygen in Order to Generate an Oxygen Equilibrium CurveUSPTOApplication 18379919
  • PendingSystem, Apparatus, And Method Of Testing A Blood Sample Or A Non-blood Sample Capable Of Transporting Oxygen In Order To Generate An Oxygen Equilibrium CurveUSPTOApplication PCTUS2023035293
  • PendingMethod Of Measuring An Oxygen Equilibrium Curve Of A SampleUSPTOApplication 63380571

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .